Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Transplant Diagnostics Market by Type (Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation), By Application (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Transplant Diagnostics Market by Type (Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation), By Application (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 320798 4200 Medical Devices & Consumables 377 213 Pages 4.6 (48)
                                          

Market Overview:


The global transplant diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of organ failures, rising demand for organ transplants, and technological advancements in transplant diagnostics. The solid organ transplantation segment is expected to account for the largest share of the global transplant diagnostics market in 2018. This segment is driven by the increasing number of solid organ transplants being performed across the globe due to rising incidence of end-stage renal disease (ESRD) and other diseases that require a solid organ transplant for treatment. The hospitals & transplant centers segment is expected to account for the largest share of the global transplant diagnostics market in 2018. This segment is driven by factors such as growing demand for diagnostic services, increase in number of patients requiring transplants, and rise in healthcare expenditure globally.


Global Transplant Diagnostics Industry Outlook


Product Definition:


Transplant diagnostics is a branch of medicine that deals with the diagnosis and treatment of conditions that may affect transplanted organs. The importance of transplant diagnostics is that it allows doctors to identify and treat any problems that may occur with a transplanted organ, which can help to ensure its long-term function.


Solid Organ Transplantation:


Solid organ transplantation is the process of replacing damaged or diseased organs by removing them from the donor and placing them into the body of a recipient. The most common forms are kidney, liver, heart, lung transplants.


The solid organ transplantation has been around for quite some time but it was not until recently that it gained widespread acceptance due to technological advancements such as improved preservation techniques and cold storage facilities along with an increase in awareness levels amongst patients & healthcare professionals.


Stem Cell Transplantation:


Stem cell transplantation is the process of replacing or restoring damaged cells and tissues by sourcing them from an individual or source that is genetically similar to the damaged one. Stem cell transplants are used in various applications such as research, clinical trials, and therapeutic treatments. The stem cells can be obtained from bone marrow, adipose tissue, cord blood (placenta), embryonic stem cells (ESCs), adult stem cells (ASCs), dental pulp, dental matrix and other sources.


Application Insights:


The market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. Hospitals and transplant centers held the largest share in 2017 due to increasing number of donors with compatible organs for donation. However, an increase in prevalence of chronic diseases such as diabetes mellitus and renal failure increases the risk of complications after organ transplantation which may lead to hospitalization or a decision for surgical treatment at a center that performs multiple transplants. In such cases, hospitals perform diagnostic procedures before organ allocation to ensure compatibility between donor and recipient which leads to higher demand for diagnostics during this period.


Research laboratories & academic institutes are anticipated to witness significant growth over the forecast period due largelyto increased R&D activities pertainingto new technologies relatedto stem cell therapiesand regenerative medicinein various regions across the globe coupled with government supportfor carrying out clinical trials on human participants.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of a large number of transplantation-related diagnostic laboratories, hospitals & transplant centers, and research laboratories & academic institutes in this region. Moreover, increasing R&D investments by private companies coupled with government support for quality healthcare delivery is expected to fuel the regional market over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising incidences of chronic diseases leading to organ failure and demand for organ transplants resulting from these diseases. In addition, improving healthcare infrastructure along with growing medical tourism in emerging countries such as China and India are expected favorably impact regional growth rate over the next eight years.


Growth Factors:


  • Increasing incidence of organ failures and the subsequent need for transplants is expected to drive the demand for transplant diagnostics over the forecast period.
  • Rising awareness about organ donation and transplantation procedures is anticipated to boost the market growth.
  • Technological advancements in transplant diagnostics are likely to provide lucrative opportunities for market players in the coming years.
  • Growing number of private clinics offering transplant diagnostic services is projected to propel market growth during the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Transplant Diagnostics Market Research Report

By Type

Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation

By Application

Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes

By Companies

BD, Biofortuna, Biomérieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche, Gendx, Hologic, Illumina, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

213

Number of Tables & Figures

150

Customization Available

Yes, the report can be customized as per your need.


Global Transplant Diagnostics Market Report Segments:

The global Transplant Diagnostics market is segmented on the basis of:

Types

Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BD
  2. Biofortuna
  3. Biomérieux SA
  4. Bio-Rad Laboratories
  5. Caredx
  6. F. Hoffman-La Roche
  7. Gendx
  8. Hologic
  9. Illumina
  10. Immucor
  11. Luminex
  12. Merck KGaA
  13. Omixon
  14. Qiagen
  15. Thermo Fisher Scientific

Global Transplant Diagnostics Market Overview


Highlights of The Transplant Diagnostics Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Solid Organ Transplantation
    2. Stem Cell Transplantation
    3. Soft Tissue Transplantation
    4. Bone Marrow Transplantation
  1. By Application:

    1. Independent Reference Laboratories
    2. Hospitals & Transplant Centers
    3. Research Laboratories & Academic Institutes
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Transplant Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Transplant Diagnostics Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Transplant Diagnostics is a company that provides diagnostic testing for transplant patients. This includes tests to check for infection, cancer, and other diseases.

Some of the key players operating in the transplant diagnostics market are BD, Biofortuna, Biom©rieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche, Gendx, Hologic, Illumina, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific.

The transplant diagnostics market is expected to register a CAGR of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transplant Diagnostics Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Transplant Diagnostics Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Transplant Diagnostics Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Transplant Diagnostics Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Transplant Diagnostics Market Size & Forecast, 2020-2028       4.5.1 Transplant Diagnostics Market Size and Y-o-Y Growth       4.5.2 Transplant Diagnostics Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Solid Organ Transplantation
      5.2.2 Stem Cell Transplantation
      5.2.3 Soft Tissue Transplantation
      5.2.4 Bone Marrow Transplantation
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Independent Reference Laboratories
      6.2.2 Hospitals & Transplant Centers
      6.2.3 Research Laboratories & Academic Institutes
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Transplant Diagnostics Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Transplant Diagnostics Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Solid Organ Transplantation
      9.6.2 Stem Cell Transplantation
      9.6.3 Soft Tissue Transplantation
      9.6.4 Bone Marrow Transplantation
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Independent Reference Laboratories
      9.10.2 Hospitals & Transplant Centers
      9.10.3 Research Laboratories & Academic Institutes
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Solid Organ Transplantation
      10.6.2 Stem Cell Transplantation
      10.6.3 Soft Tissue Transplantation
      10.6.4 Bone Marrow Transplantation
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Independent Reference Laboratories
      10.10.2 Hospitals & Transplant Centers
      10.10.3 Research Laboratories & Academic Institutes
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Solid Organ Transplantation
      11.6.2 Stem Cell Transplantation
      11.6.3 Soft Tissue Transplantation
      11.6.4 Bone Marrow Transplantation
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Independent Reference Laboratories
      11.10.2 Hospitals & Transplant Centers
      11.10.3 Research Laboratories & Academic Institutes
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Solid Organ Transplantation
      12.6.2 Stem Cell Transplantation
      12.6.3 Soft Tissue Transplantation
      12.6.4 Bone Marrow Transplantation
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Independent Reference Laboratories
      12.10.2 Hospitals & Transplant Centers
      12.10.3 Research Laboratories & Academic Institutes
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Solid Organ Transplantation
      13.6.2 Stem Cell Transplantation
      13.6.3 Soft Tissue Transplantation
      13.6.4 Bone Marrow Transplantation
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Independent Reference Laboratories
      13.10.2 Hospitals & Transplant Centers
      13.10.3 Research Laboratories & Academic Institutes
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Transplant Diagnostics Market: Competitive Dashboard
   14.2 Global Transplant Diagnostics Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 BD
      14.3.2 Biofortuna
      14.3.3 Biomérieux SA
      14.3.4 Bio-Rad Laboratories
      14.3.5 Caredx
      14.3.6 F. Hoffman-La Roche
      14.3.7 Gendx
      14.3.8 Hologic
      14.3.9 Illumina
      14.3.10 Immucor
      14.3.11 Luminex
      14.3.12 Merck KGaA
      14.3.13 Omixon
      14.3.14 Qiagen
      14.3.15 Thermo Fisher Scientific

Our Trusted Clients

Contact Us